Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
Chinese Patent Office
Fish and Richardson
QuintilesIMS
Colorcon
US Army

Generated: March 26, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Bardoxolone

« Back to Dashboard

US Patents for Bardoxolone

Glossary
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Bardoxolone ➤ Try a Free Trial Inhibitors and methods of use thereof The Trustees of Dartmounth College (Hanover, NH) ➤ Try a Free Trial
Bardoxolone ➤ Try a Free Trial CDDO-compounds and combination therapies thereof The Trustees of Dartmouth College (Hanover, NH) Board of Regents, The University of Texas System (Austin, TX) ➤ Try a Free Trial
Bardoxolone ➤ Try a Free Trial Synthesis and biological activities of new tricyclic-bis-enones (TBEs) Trustees of Dartmouth University (Hanover, NH) ➤ Try a Free Trial
Bardoxolone ➤ Try a Free Trial CDDO-compounds and combination therapies thereof Board of Regents, The University of Texas System (Austin, TX) The Trustees of Dartmouth College (Hanover, NH) ➤ Try a Free Trial
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Patents for Bardoxolone

Glossary
Drugname Country Document Number Estimated Expiration Related US Patent
Bardoxolone Australia 2003303128 2022-05-13 ➤ Try a Free Trial
Bardoxolone Canada 2485565 2022-05-13 ➤ Try a Free Trial
Bardoxolone European Patent Office 1507541 2022-05-13 ➤ Try a Free Trial
Bardoxolone Japan 2006515859 2022-05-13 ➤ Try a Free Trial
Drugname Country Document Number Estimated Expiration Related US Patent

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
Deloitte
McKinsey
Johnson and Johnson
QuintilesIMS
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2019 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
Major Patent Expirations 2019 - 2020
 NCE-1 Generic Application Dates 2019 - 2020
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2019, www.DrugPatentWatch.com.
Links

Follow DrugPatentWatch: